-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Abbott Laboratories, Raises Price Target to $145

Benzinga·04/17/2025 16:11:42
Listen to the news
RBC Capital analyst Shagun Singh maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price target from $140 to $145.